RANKL- and CSF-1-induced increased ISG15 levels were decreased by pre-treatment with BAY11-7082, an NFκB inhibitor that inhibits IκBα phosphorylation; however, this did not reach statistical significance.
← all excerpts
RANKL and CSF-1 are elevated in periovulatory follicular fluid of BRCA1 mutation carriers and increase proinflammatory signaling in fallopian tube epithelial cells.
1
—
—